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Patients with artificial joints: do they need antibiotic cover
for dental treatment? 
JF Scott,* D Morgan,† M Avent,‡ S Graves,§ AN Goss
Abstract
This study reviews whether patients with artificial
joints need antibiotic cover for dental treatment.
Generally in Australia the practice has developed of
giving most patients with artificial joints antibiotic
prophylaxis for a wide range of dental procedures.
This is partly on anecdotal grounds, partly historical
and partly for legal concerns. It has been encouraged
by some guidelines. Scientifically, the risk and the
benefit of each step in the process needs to be
analysed. This review shows that the risk of an
artificial joint becoming infected from a bacteraemia
of oral origin is exceedingly low whereas the risk of
an adverse reaction to the antibiotic prophylaxis is
higher than the risk of infection. If all patients with
artificial joints receive antibiotic prophylaxis then
more will die from anaphylaxis than develop
infections. Factors which balance the risk benefit are
if the patient is seriously immunocompromised, if
the joint prosthesis is failing or chronically inflamed
and if the dental procedures, such as from
extractions and deep periodontal scaling, produce
high level bacteraemias. Recommendations to
rationalize antibiotic prophylaxis for patients with
artificial joints are presented.
Key words: Artificial joints, antibiotic prophylaxis, dental
treatment.
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preferential deposit of bacteria which have localized
out of the bloodstream into areas of inflammation.4
The legal involvement relates to the warnings which
come with most American manufactured orthopaedic
implants to the effect that antibiotics should be given
for all dental treatment for patients receiving the
implant. This broad advice is given partly for
commercial but largely for legal concerns.
However, like all traditions in health, these need to
be subject to evidence-based risk benefit analysis to test
whether in fact they are true. After an overview of the
current status of orthopaedic implants, the following
steps require analysis (Fig 1): (1) Can bacteria enter the
bloodstream from oral pathology or dental treatment?
(2) Under what circumstances do oral bacteria settle in
distant parts of the body? (3) Can orthopaedic implants
become infected by blood-borne oral bacteria? (4) Can
oral bacteria be prevented from entering the
bloodstream or from infecting orthopaedic implants by
the prescription of antibiotics? (5) What are the risks of
antibiotic therapy?
The purpose of this review is to perform a risk
benefit analysis of the evidence for the indications to
prescribe antibiotic cover for dental treatment in
patients with artificial joints. On this basis evidence-
based management recommendations are made.
Overview of the current status of orthopaedic
implants
Joint replacement is a proven cost-effective medical
procedure.5 From small beginnings with hip
replacements in the 1950s, it has greatly expanded to
include the knee, ankle, shoulder, elbow and finger
joints. Generally these joint replacements are successful
with an over 90 per cent success rate over a 10-year
period.6 The effectiveness of joint replacement coupled
with the increasing age of the population has resulted
in ever expanding numbers of artificial joints being
placed. For example, in the United States in 1995, 
243 919 total knee replacements were performed.6 In
Australia in the financial year 2002-2003, there were
27 833 hip replacements and 28 003 knee replace-
ments. The total number of hip and knee replacements
has increased from 32 006 in 1994-1995 to 55 836 in
2002-2003. This represents an increase of 74.5 per cent
during the eight-year period.7
Placement of artificial joints requires strict attention
to detail with full evaluation of the patient, careful
selection of the prosthesis and full informed consent.
Patients specifically should be checked for sources of
INTRODUCTION
‘Patients with artificial joints: do they need antibiotic
cover for dental treatment?’ The traditional
orthopaedic answer and, to a lesser extent, dental
answer to this question is in the affirmative.1,2 The basis
to this tradition is partly anecdotal, partly historical
and partly legal. Anecdotally there have been isolated
cases of joint infection related to dental disease or
treatment.3 Historically, at the turn of the last century,
focal infection theory held that many illnesses were
caused by foci of infection within localized areas in the
body causing systemic illness. One of the key sources of
focal infection was the teeth and widespread dental
extraction was the main outcome. The basis of this
theory was by the process of anachoresis which is the
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potential bacteria or contamination of skin, oral,
dental, bowel or urinary origin and, where possible,
treated pre-operatively. Once the decision has been
made to proceed, patients are usually admitted on the
day of surgery. In theatre considerable effort is made to
reduce the likelihood of operative infection. All patients
have full surgical site antimicrobial preparation and are
given high doses of intravenous prophylactic antibiotics
at the commencement of the operation. Intravenous
antibiotic prophylaxis with cephazolin is administered
at induction of the procedure and continued for 24
hours. If the patients have a type I allergy to penicillin
or cephalosporins, or if they are at high risk for MRSA
colonization or infection, vancomycin should be used
instead of cephazolin.8,9 The operation should be
performed by experienced surgical personnel in a
dedicated operative suite (Figs 2a and 2b). The theatre
should be equipped with vertical laminar flow units or
at the very least be a high flow theatre. It is also
common for operating staff to wear body exhaust suits,
although the evidence for the advantage of this when all
other techniques aimed at reducing infection are
utilized remains uncertain. In addition, in procedures
where prothesis requires bone cement (methylmetha-
crylate) fixation, it is common to use antibiotic
containing bone cement.
Placement of artificial joints involves hard and soft
tissues reactions to the surgery and to the implant. In
broad terms the bone reaction follows the same stages
of healing as for bone fractures, namely, initial
haematoma formation, an inflammatory reaction,
callus formation, bone remodelling and new bone
formation.10 In general terms and in the absence of
complications the process is largely complete within
S46 Australian Dental Journal Medications Supplement 2005;50:4.
Fig 1. Schematic representation of the steps involved in an analysis
of the risk and benefits of antibiotic prophylaxis to prevent
infection of artificial joint replacements by oral bacteria.
Fig 2a. Total joint operating theatre.
Fig 2b. Intra-operative picture of a total knee replacement.
Fig 3a. Total knee replacement – lateral view.
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two to three months although subtle bone remodelling
continues for 12-24 months (Figs 3a and 3b).
Joint replacements may fail for a multiplicity of
reasons which include: infection, both early and late;
loosening of the joint components; fracture of the joint
components; wear of the prosthetic articular surface;
excessive inflammatory reaction to wear particles; and
bone fracture and iatrogenic factors relating to the
surgical technique.11 All of these factors have been
exhaustively analysed but apart from infection will not
be considered further in this study.
A number of comorbidities have been identified that
increase the risk of implant failure due to infection. Key
ones are immunosuppressive therapy, immuno-
suppressive conditions such as diabetes mellitus,
rheumatoid arthritis, cancer, general poor medical
condition, obesity and smoking.9 Also, the younger the
patient at the time of first implantation, the greater the
chance it will fail, probably because of increased
activity before the patient’s death of other causes. When
a joint replacement fails it will have significant
consequences to the patient in terms of pain, disability,
greater risks associated with any subsequent surgery
and increased costs both to the patient and the health
care system (Figs 4a and 4b). Failed joints require
careful analysis of the reason for failure. Treatment
options will depend on the reason for failure, including
removal of the joint, revision and replacement of part
or all of the joint, joint fusion for failed knee
replacement or rarely amputation of the limb. In
general there are significantly greater and more
complex problems associated with the management of
failed artificial joints than with the primary
placement.8,9 Revision surgery has a much higher risk of
complication including infection and an increased
mortality risk.
Interestingly to the dental profession, attempts at
replacing the temporomandibular joint with its
complex anatomy, small size but high load, have been
much less successful than replacement of limb joints.
Fig 3b. Total knee replacement – AP view.
Fig 4a. Failed septic knee replacement – lateral view.
Currently there is no routinely available temporo-
mandibular joint for implantation although a number
are under research evaluation.
Can bacteria enter the bloodstream from oral
pathology and dental treatment?
There is substantial soundly-based scientific
literature on this.12,13 Clinical research protocols involve
the placement of intravenous access with micro-
biological cultures at fixed times following
physiological or treatment events. Oral bacteria clearly
do enter the bloodstream during chewing, teeth
clenching and toothbrushing although the amounts are
small and transient.14 Quantitatively, the bacteraemia is
greater if the patient has periodontal disease.15 The
greatest amount of bacteraemia occurs following
extraction of erupted, periodontally involved teeth.
There is less bacteraemia from unerupted teeth or from
removal of asymptomatic mandibular fracture fixation
plates.16
Generally, the bacteraemia can be demonstrated
within one minute of the manipulation and is usually
greatest five minutes following the procedure. Bacteria
usually cannot be demonstrated in the bloodstream at
30 minutes after manipulation. Most studies show
aerobic bacteria in the bloodstream, the most common
types being viridans group streptococci although most
of the common oral commensals can be demonstrated.
If a thorough and an extensive culture for anaerobic
bacteria is performed then anaerobic bacteria will be
demonstrated. These are dominated by Actinomyces,
campylobacter bacteria and lactobacillus species.
Commonly, with careful culture, the anaerobic bacteria
will form up to 85 per cent of all the bacteria in the
bloodstream.17
General dental treatment such as local anaesthetic
injection, fillings, impressions and dentures do not
cause significant bacteraemia above those which occur
in normal chewing or toothbrushing.14 The most
significant bacteraemias are produced by extraction of
standing teeth, particularly if there is associated
periodontal disease. Similar levels of bacteraemia are
generated by deep periodontal scaling in the treatment
of periodontal disease.18
There is a group of intermediate dental procedures
e.g., deep matrix band placement with interdental
wedging, rubber dam clamps and endodontic
manipulation, beyond the apex where there are
significant periapical areas.19 In general the longer the
dental manipulations continue the greater the
bacteraemia (Table 1).
It needs to be understood that the oral cavity is not
the only site of bacteraemia. Skin, bladder and gut all
have resident flora and all have been demonstrated to
result in transient bacteraemia. A considerable
bacteraemia will result from colonoscopy for patients
with inflammatory bowel disease such as diverticulitis.9
Under what circumstances do oral bacteria settle in
distant parts of the body?
Although there is lengthy anecdotal history that a
dental disease and treatment will result in bacterial
colonization at different sites of the body, there is little
clinical or experimental evidence to scientifically show
that this is true.
Bacteria within the bloodstream pass into areas of
acute inflammation as there is increased vascularity.
Dependent on the nature of inflammatory reaction this
may increase or decrease the destruction of bacteria.
With the specific types of inflammatory response relating
S48 Australian Dental Journal Medications Supplement 2005;50:4.
Fig 4b. Failed septic knee replacement – AP view.
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to rheumatoid arthritis or from a reaction to wear
particles it would appear that they may make a failing
implant more prone to infection. In areas of chronic
inflammation, where there are concurrent areas of
inflammation and necrotic tissue, there is a possibility of
colonization into the less vascular areas of necrosis and
thus a greater chance of bacterial colonization.
In this context it should be noted that in bacterial
endocarditis where bacteria from the bloodstream
colonize damaged heart valves, the key issue is
abnormal blood flow with turbulence about the valves.
This allows the bacteria to settle and attach to the
valves. Heart valves are relatively avascular and thus
the bacteria have the opportunity to colonize in the
absence of an inflammatory response.20 Heart valves
may also be damaged by bacteria in an immunological
response. The classic example is in rheumatic fever
where streptococci in the oropharynx provoke an
immunologic response with secondary damage to the
heart valves as there are similarities in structure
between the bacterial walls and the heart valve. This,
however, is not a bacterial infection.
The probable basis for most foci of infection type
disease is where the presence of foci of bacteria relate to
general systemic unhealthiness. Thus once the focus of
infection is removed and as the patients recover, they
feel better. Again this is not through distant bacterial
colonization (Table 1).
Cerebral abscess is an example of where oral bacteria
may lodge at distant sites.21 There are a few cases in
which the organisms are demonstrably oral bacteria
from the patient’s mouth. The only reasonable portal of
entry would be via the bloodstream. Usually it is
considered there has been some form of haemodynamic
variation in the brain or some form of prior brain
injury to act as the site for the bacterial colonization.
Can orthopaedic implants become infected by blood-
borne bacteria?
There is extensive soundly-based scientific literature
on this.1,6,8-10 It is important that all papers which set out
to document joint infections have meticulous
methodology as it is easy for the source of the infection
to be based on anecdote. Ideally, to confirm that an
implant has been infected from an oral treatment, one
requires a coincidence history and an accurate and
simultaneous typing of the oral flora bacteraemia and
joint organisms.1 These steps have not usually been
taken in most investigations in the literature and some
papers are based solely on history.
Infection following a joint replacement is a
devastating complication.8,9 All require intensive and
prolonged treatment. In one study of a consecutive
series of infected hip replacements, 58 per cent were
successfully re-implanted with a further artificial joint
after a resolution of the infection, 34 per cent had
implant removal but no replacement but local tissue
flaps; 4 per cent had leg amputation at the level of the
hip and 5 per cent of the patients died.9
Infections in joint replacements are divided into early
or late occurring.8,9 Early infections, that is within the
first three months following implantation, primarily
relate to infection introduced at the time of the
operation, either sourced from the patient or the
surgical staff. The incidence of this is low and of the
order of 0.39 per cent.9
Later infections, more than three months after
primary implantation, are usually secondary to
bacteraemia. The incidence is low and of the order of
0.97 per cent.22 The prevalent bacteria are
Staphylococcus aureus (35 per cent) and Staphylococcus
epidermidis (15 per cent). These are of skin origin.
Some or most of these may even have been introduced
at the time of surgery but have a delayed presentation.
Group A streptococci, which are mainly of
oropharyngeal origin, occurred in about 8 per cent of
cases. Escherichia coli, which is the classic alimentary
tract bacteria, were involved in about 4 per cent of
cases. Thus bacteraemic-related joint infections may
occur but generally at a low incidence. Skin organisms
are the predominant group. The risk of oral-related
infections is very low with figures in the range of 0.04-
0.07 per cent23,24 (Table 1).
There are a number of publications on the risk of joint
infections. Laporte et al. reviewed 2973 cases of joint
replacements and found that 52 had late infections.2
They were of the opinion that three of these were
‘strongly associated’ with a dental procedure. Two of
Table 1. The relative incidence of bacteremia, distant bacterial colonization and adverse response to antibiotics
Event – Dental treatment Risk of occurrence
• Bacteraemia during chewing <70% But small numbers and transient
• Bacteraemia during non-surgical dentistry <70% But small number and transient
• Bacteraemia during dental extraction in patient with 100% Large number of bacteria both aerobic and anaerobes
periodontal disease
• Bacteraemia during deep periodontal scaling 100% Large number of bacteria both aerobic and anaerobes
• Distant colonization from oral bacteria 0% Not recorded in healthy individuals
• Brain abscess Occasional Individual reports
• Infected joint prosthesis 0.03 to 0.07% More likely in immunocompromised patient
• Allergic to antibiotics Usually known
• Urticaria 3-5% Allergic history
• Anaphylaxis 1 in 2500 to 5000
• Death from anaphylaxis 1 in 25 000 to 50 000
these three patients had additional risk factors, namely,
diabetes and rheumatoid arthritis. None of the three
patients had received prophylactic antibiotics and all of
the dental procedures had lasted more than 45 minutes.
Waldman, in an extensive review of 3490 patients
with knee arthroplasties, found 62 cases of late
infection of which only seven had a dental association
but over half of these had systemic risk factors.25 Little,
in a prospective study of 1000 patients, had three
patients develop late joint infections. None of these
were related to dental treatment.
Maderazo, in a review of 100 late joint infections,
found that 34 of the patients had invasive health
procedures performed coincident with the infection.24
Five of these patients had dental treatment and all
received prophylaxis. Ainscow and Denham followed
1000 patients with 1112 total joint replacements for up
to six years. Of these, 224 had received dental
treatment. However, not all the patients were
administered prophylactic antibiotics and none had
documented joint infection.26 Jacobson investigated
2693 patients with whom 30 developed late joint
infections. Of these, nine of the 30 were type II
diabetics or on long-term immunosuppression.27
Besides dental treatment there is also the matter of
untreated dental disease. Ching et al. described four
cases with late infections with Streptococcus viridans in
patients who had poor oral health.28 A further four
cases with haematogenous Streptococcus sanguis joint
infection without dental treatment but oral sepsis
demonstrated the need for good oral hygiene.29
Can oral bacteria be prevented from entering the
bloodstream or from infecting orthopaedic implants
by antibiotic treatment?
This question has been demonstrated in clinical studies
where blood cultures are performed following dental
treatment with appropriate prophylactic antibiotic
coverage.30-32 The incidence and magnitude of
bacteraemia after an extraction does not decrease.
However, the antibiotics inhibit bacterial growth at the
localized site of bacterial colonization but there is no
certainty that antibiotics will prevent the infection as
evidenced in the Maderazo study where all five patients
with apparently oral-related bacteria as the source of the
infection of joint replacements received prophylactic
antibiotic cover.24 Conversely, dental treatment with or
without prophylactic antibiotic therapy resulted in 224
out of 1000 consecutive joint replacement patients not
having joint infection. However, three of the remaining
776 patients who did not have dental treatment or
receive prophylactic antibiotics had late joint infections
of orally-related bacteria.23 The authors did not specify
what the patients’ oral health state was at the time of the
infection.
What are the risks of antibiotic therapy?
Antibiotics are not harmless medications and all are
associated with side effects and adverse reactions. For
the penicillin group the risk of an urticaria type
reaction is between 3-5 per cent.33 Though this is not
life-threatening it is a temporary but significantly
disabling condition. Anaphylaxis is a life-threatening
condition and without immediate treatment may result
in death. The risk of anaphylaxis to penicillin type
antibiotics is quoted at 1 in 2500 to 5000.34 The risk of
a fatal anaphylaxis is 10 per cent of all cases of
anaphylaxis. There are also the associated risks of
increased bacterial resistance to the commonly
prescribed antibiotics and the development of multi-
resistant strains.35
Risk benefit analysis
Although bacteraemia is likely to occur following
dental procedures the bacteria are transient and the
incidence of joint infections related to the
haematogenous route is low. In addition, the literature
does not support prophylactic antibiotic therapy for
dental treatment and it is inappropriate to expose
patients to the adverse effects of antibiotics.
There is a small, recent and thorough scientific
literature which supports this risk benefit analysis.
Seymour calculated that if 100 000 patients had a joint
replacement then 30 would have a late infection about
the prosthesis which would require treatment. If all
were given penicillin antibiotics then there would be 40
cases of anaphylaxis and four deaths.36
Jacobson calculated that the risk of death from
penicillin outweighs the benefit of prescribing it.27 The
adverse effects are more common and harmful than the
occasional case of joint infection that it may prevent.
Besides anaphylaxis and other allergic reaction he also
highlighted the problems of gastro-intestinal
disturbance and the development of resistant strains.
Analysis of health costs leads to a similar conclusion.
It is cheaper to treat the occasional case of joint
infection than to fund antibiotics and the cost of
adverse sequelae. Jacobson calculated that, on 1990
costs, the cost of preventing one case of joint 
infection by widespread antibiotic prescription was
US$480 000.27
However, there is a small group of patients with
current infection who require prompt treatment with
appropriate antibiotics. There is a greater risk of joint
replacement infection when there is untreated oral
sepsis, or dental procedures involving extraction, or
deep periodontal curettage for patients with significant
periodontal inflammation, for artificial joints with pre-
existing local inflammation from either initial
placement or from prosthetic failure. When these
factors are present the benefits of antibiotic therapy
exceed the risks.
DISCUSSION
This review shows that the traditional management
practice of providing antibiotic cover for all dental
treatments for patients with artificial joints is not
necessarily justified and, indeed, could be potentially
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dangerous. Altering traditional beliefs and health
conventions, however, is never easy. The current classic
example is the misuse of antibiotics in medical and
dental practice.37 All medical practitioners know that
an upper respiratory tract infection is viral but over 50
per cent will prescribe antibiotics. Most dentists know
that toothache in the absence of localizing clinical and
radiographic signs is not bacterial but many will still
prescribe antibiotics ‘just in case’. Many medical and
dental practitioners will agree that in such
circumstances antibiotics are inappropriate but
prescribed anyway as the patient ‘demanded
antibiotics’. Intensive public and health professional
education programmes are now just showing evidence
of working. Some patients understand that antibiotics
are not the be all and end all and there has been a
plateauing of the antibiotic prescription rate. This,
however, has taken much time and effort and there is
still a long way to go.37
There are a number of antibiotic prophylaxis
guidelines which have been produced by national
bodies. In July 2003, the American Dental Association
published an advisory statement in association with the
American Academy of Orthopaedic Surgeons
‘Antibiotic prophylaxis is not routinely indicated for
most dental patients with total joint prosthesis but it
may be advisable to consider pre-medication in a small
number of patients who may be at potential risk of
experiencing haematogenous joint infections’.38 This is
a major change in attitude by the Americans. The
article contained a table which indicated risk groups.
These related mainly to patients who were
immunocompromised.
The British National Formulary has a similar review
which looks at the rationale behind the guidelines and
examines the issues from a risk management point of
view.39 It emphasizes that the risk of antibiotic
prophylaxis outweighs the risk of joint infection. It also
emphasizes the need for communication between
orthopaedic surgeons and dentists. It confirms that
within broad guidelines all patient situations are
individual and this requires individual communication,
co-operation and treatment plans.
The Australian guidelines for the use of drugs in
dentistry state that there is no evidence of the infection
of implants associated with dental treatment.40 It then
goes on to state that if patients are immunosuppressed,
if extensive surgery is performed or if established
infection is present, antibiotic prophylaxis should be
provided.41 This fairly strong statement has been widely
interpreted by many dental practitioners to provide
antibiotic cover for most patients with artificial joints.
The corresponding author’s institution guidelines for
antibiotic prophylaxis, across the Royal Adelaide
Hospital campus, were formulated in 1999 and revised
in 2003.42 This was under the leadership of the
Antibiotic Working Party, a sub-committee of the Drug
Committee and it involved extensive consultation. This
guideline has to a degree regulated what had been a
highly individualistic approach to common problems.
For patients with joint replacements, they agree that
antibiotic prophylaxis was only indicated for high-risk
dental procedures in immunocompromised patients
with joint problems.
A guideline based on this review is presented in Table
2. Logically, the first step should be that all patients
undergoing joint replacement should be dentally fit.
This should be determined by a dentist after full oral
examination and radiographs. The common situation
of the orthopaedic surgeon asking the patients if their
teeth are ‘OK’ is not enough. Interestingly, the
corresponding author in 35 years of public and private
practice cannot recall ever having been asked to check
a patient’s mouth for fitness or otherwise prior to joint
replacement. Such referral, however, has been made a
few times for patients presenting with an established
joint infection. Cardiology and organ transplant
candidates in South Australia are routinely referred for
an oral health review.
Table 2. Recommendation for dental treatment of
patient with artificial joint replacement
Prior to placement of the first artificial joint
Referral to a dental practitioner for comprehensive dental
examinations including radiographs.
Appropriate treatments as indicated to make the patient orally fit.
Dentist if requested give a written opinion that the patient is orally
fit with no evidence of oral infection.
Arrangements made for regular dental review.
Dental problem in the first 3 months following artificial joint
placement
Infection with abscess formation: Urgent and aggressive treatment
of the abscess. Remove the cause (exodontic or endodontic) under
antibiotic prophylaxis.
Pain: Provide emergency dental treatment for pain. Antibiotics are
indicated if a high- or medium-risk dental procedure performed.
Noninfective dental problem without pain: Defer nonemergency
dental treatment until 3 to 6 months after prosthesis replacement.
Dental treatment after 3 months in a patient with a normally
functioning artificial joint
Routine dental treatment including extraction. No antibiotic
prophylaxis required.
No antibiotic prophylaxis required.
Regular dental review desirable.
Dental treatment for patients with significant risk factors for
artificial joint infection
Immunocompromised patients include:
• those with insulin-dependent diabetes
• those taking immunosuppressive treatment for organ transplants
or malignancy
• those with systemic rheumatoid arthritis
• those taking systemic steroids (e.g., patients with severe asthma,
dermatological problems)
Consultation with the patient’s treating physician is recommended.
Failing, particularly chronically inflamed, artificial joints: 
Consultation with the patient’s treating orthopaedic surgeon is
recommended.
Defer non-essential dental treatment until orthopaedic problem has
resolved.
Previous history of infected artificial joints:
Routine non-surgical dental treatment – no prophylaxis indicated. 
Antibiotic prophylaxis recommended for: 
• all extractions
• deep periodontal scaling
Regular dental reviews mandatory.
Established infection by oral organisms on an artificial joint
Urgent referral to dentist to determine and eliminate any oral cause.
Aggressive treatment by removal of the cause, extraction or
endodontic under antibiotic prophylaxis.
Dental treatment in the pre-implantation phase
should be aggressive to eliminate current foci of
infection. If the condition cannot be rapidly resolved by
restorative, endodontic or periodontal treatment the
involved teeth should be extracted. Antibiotic
prophylaxis would not usually be required for such pre-
implantation treatment.
In the initial phase following placement of joint
prosthesis dental treatment would not normally be
required if the patients have been made dentally fit
prior to the procedure. The patients in this first three-
month phase after receiving a prosthetic joint are
usually in some orthopaedic discomfort and usually15
not sufficiently mobile for routine dental treatment. If a
dental infection arises it should be treated aggressively
by endodontics or extraction with appropriate
therapeutic antibiotics. Once a joint prosthesis is
stabilized and functioning well, routine dental
treatment including extractions in the absence of gross
periodontal disease do not require antibiotic
prophylaxis. However, antibiotic prophylaxis should be
prescribed for patients who have already had an
episode of replacement for an infected prosthesis as this
may indicate that they are at increased risk of
developing an infection. Standard antibiotic
prophylactic regimens are presented in Table 3.
Finally, there remains the currently not uncommon
scenario where patients demand that they have
antibiotic treatment for all dental treatment because
their orthopaedic surgeon has advised them that they
should. In that case one does need to carefully evaluate
the precise nature of the dental problem and the
treatment needs. One then needs to communicate with
the patient’s orthopaedic surgeon so that the actual risk
benefit situation can be determined. If there is no
indication for antibiotic prophylaxis in accordance
with these guidelines but the orthopaedic surgeon is
insistent that antibiotics are given, then an informed
consent decision needs to be made. If antibiotics are
requested, it needs to be recorded that the orthopaedic
surgeon requested prophylaxis be given. Hence the
orthopaedic surgeon would bear the responsibility for
any adverse outcome related to the administration of
the antibiotic therapy.
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